SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is experiencing intense bullish momentum, driven by spot silver prices reaching new all-time highs. This rally is fueled by tightening global supply due to upcoming Chinese export restrictions, alongside booming industrial demand from EV batteries, solar, and AI data centers. The community is actively discussing a potential 'silver squeeze' and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

Alpha Capital Acquisition Co. (ASPC) is actively trending as a low-float SPAC, driving intense discussion and trading activity within the community. Traders are eyeing its potential for a short squeeze due to reported high short interest and limited shares, though many also caution about its history of significant volatility and quick reversals.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending amid community discussion regarding China's recent sanctions, widely seen as a bullish validation of its strategic importance in the defense sector. This comes as the U.S. implements a ban on foreign-made drones and components, fueling expectations for substantial defense budget allocations and significant contract awards for American-made small drones and unmanned surface vessels. The company's increasing production capacity is highlighted as a critical factor in capturing this anticipated demand.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending amidst surging global silver prices, particularly hitting new highs in Shanghai, which has fueled widespread community frustration over AG's perceived lag and market manipulation. Despite this, investors are bullishly anticipating a significant "catch-up" rally for the stock, driven by strong underlying silver fundamentals and recent company updates, viewing the current disconnect as a prime buying opportunity for substantial upside potential.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is trending as a low-float IPO benefiting from renewed interest in the broader space sector. The community is actively discussing extremely high borrow fees and limited short availability, fueling strong speculation about a significant short squeeze. However, some investors express caution regarding the company's long-term fundamentals and potential for future share dilution.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang is heavily trending due to a significant customer data breach that has triggered intense government scrutiny and a recent leadership change. While some community members voice strong concerns over potential consumer boycotts, lawsuits, and severe regulatory penalties, others contend the actual impact may be less severe than initially feared, viewing the stock as oversold. The e-commerce giant's dominant position in South Korea is now being tested by these evolving operational and reputational challenges.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining Inc. is trending as silver achieves new highs and gold confirms a breakout, igniting significant bullish sentiment among investors anticipating further upside. The company's recent strategic acquisition of New Gold is a key discussion point, with the community actively debating its potential for long-term production and free cash flow growth versus initial dilution impacts.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending as its energy-efficient APU chip gains attention following independent validation for AI workloads, positioning it as a potential disruptor in edge computing for drones and defense. While many investors are enthusiastic about its compute-in-memory architecture and recent government contracts, a strong debate exists within the community regarding its commercial viability and future prospects.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is experiencing a significant rally following reports of a substantial investment by TOMS Capital Investment Management, igniting widespread community buzz and driving notable upward price action. This strong momentum, highlighted by a series of green days and bullish sentiment, is further supported by broader positive retail sector trends and improving shrink reduction efforts, fueling speculation for a sustained comeback.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is a trending topic following a major contract win from the Space Development Agency, which significantly boosts its backlog and solidifies its role as a defense prime. This has ignited strong bullish sentiment within the community, with many anticipating continued upside, while others point to potential overvaluation and recent insider sales as reasons for caution. The company's expanding space systems capabilities and the broader sector's momentum are key discussion points among investors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$LFCR &quot;Heads up alert! Upcoming earnings on Friday, 10/3/2025 for $LFCR 
Bullish (8.1) 
 
### Financial Analysis: 
 
Lifecore Biomedical, Inc. 
(NASDAQ: LFCR) has recently displayed strong momentum in the stock market, underpinned by a significant 10.8% increase in share price. 
This upward trajectory is supported by positive earnings estimate revisions, indicating potential for continued strength. 
The company&#39;s intrinsic value, calculated using a two-stage Free Cash Flow to Equity model, suggests that its share price is undervalued by approximately 44%, with an estimated fair value of $10.99. 
This valuation disparity highlights a promising opportunity for investors, particularly as Lifecore continues to expand its presence in the contract development and manufacturing organization (CDMO) sector. 
In terms of financial metrics, Lifecore&#39;s recent earnings report surpassed expectations, bolstering investor confidence. 
The company&#39;s Price-to-Earnings (P/E) ratio remains competitive within the industry, suggesting it is attractively valued relative to its earnings growth prospects. 
Lifecore&#39;s earnings per share (EPS) growth has been robust, further enhancing its appeal to growth-oriented investors. 
The company&#39;s ability to consistently outperform market expectations underscores its strong operational execution and strategic positioning within the CDMO space. 
### Upcoming Earnings Report: 
 
Looking ahead to upcoming earnings reports, Lifecore is expected to maintain its positive momentum. 
Historical performance has shown a pattern of exceeding analyst consensus estimates, which could contribute to sustained stock appreciation. 
Analysts are closely monitoring Lifecore&#39;s revenue forecasts, particularly in light of its participation in key industry conferences and its strategic initiatives to drive growth. 
Any positive surprises in the upcoming earnings release could act as a catalyst for further price appreciation. 
### Sector Performance: 
 
Lifecore operates within the broader healthcare and pharmaceutical manufacturing sector, which has experienced varied performance. 
The sector is characterized by robust demand for CDMO services, driven by increasing pharmaceutical outsourcing needs. 
Lifecore&#39;s strategic focus on leveraging its integrated manufacturing capabilities positions it well to capitalize on these industry trends. 
While the sector faces regulatory and competitive challenges, Lifecore&#39;s recent achievements and market positioning suggest it is poised to outperform its peers in the near to medium term. 
In summary, Lifecore Biomedical appears to be on a promising trajectory, supported by strong financial fundamentals, undervaluation relative to intrinsic value, and favorable industry dynamics. 
Investors should consider the stock&#39;s potential for continued upside, subject to the broader market conditions and sector-specific developments. 
 
- Funds were net buyers of $LFCR during the previous reporting quarter. 
 
- Funds with large holdings in $LFCR include: 
 
- Last 10 days performance: -6% 
- Last 30 days performance: -7% 
- Last 90 days performance: -14% 
 
Some of the latest news articles: 
 - Title: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 
Publication Date: 9/23/2025 8:30:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/lifecore-announces-inducement-grant-under-203000341.html?.tsrc=rss 
 
 - Title: Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock? 
Publication Date: 9/12/2025 1:09:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/lifecore-biomedical-lfcr-soars-10-130900522.html?.tsrc=rss 
 
 - Title: Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference 
Publication Date: 9/4/2025 8:05:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/lifecore-biomedical-participate-24th-annual-200500631.html?.tsrc=rss 
 
 - Title: Lifecore Biomedical to Participate in Upcoming Investor Conferences 
Publication Date: 9/2/2025 8:05:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/lifecore-biomedical-participate-upcoming-investor-200500024.html?.tsrc=rss 
 
Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal.&quot;

CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc.

Yahoo Finance

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Lifecore Biomedical (LFCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock?

CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that the company will participate at the 24th Annual Contract Pharma Contracting and Outsourcing Conference.

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that the company will participate in multiple upcoming investor conferences.

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.

Stocktwits

Stocktwits - Stock Market Live Quotes, Social Community Discussions, News, Stock Rankings & Earnings

StockTwits Web

Lifecore Biomedical Inc

 "Heads up alert! Upcoming earnings on Friday, 10/3/2025 for 

 
Bullish (8.1) 
 
### Financial Analysis: 
 
Lifecore Biomedical, Inc. 
(NASDAQ: LFCR) has recently displayed strong momentum in the stock market, underpinned by a significant 10.8% increase in share price. 
This upward trajectory is supported by positive earnings estimate revisions, indicating potential for continued strength. 
The company's intrinsic value, calculated using a two-stage Free Cash Flow to Equity model, suggests that its share price is undervalued by approximately 44%, with an estimated fair value of $10.99. 
This valuation disparity highlights a promising opportunity for investors, particularly as Lifecore continues to expand its presence in the contract development and manufacturing organization (CDMO) sector. 
In terms of financial metrics, Lifecore's recent earnings report surpassed expectations, bolstering investor confidence. 
The company's Price-to-Earnings (P/E) ratio remains competitive within the industry, suggesting it is attractively valued relative to its earnings growth prospects. 
Lifecore's earnings per share (EPS) growth has been robust, further enhancing its appeal to growth-oriented investors. 
The company's ability to consistently outperform market expectations underscores its strong operational execution and strategic positioning within the CDMO space. 
### Upcoming Earnings Report: 
 
Looking ahead to upcoming earnings reports, Lifecore is expected to maintain its positive momentum. 
Historical performance has shown a pattern of exceeding analyst consensus estimates, which could contribute to sustained stock appreciation. 
Analysts are closely monitoring Lifecore's revenue forecasts, particularly in light of its participation in key industry conferences and its strategic initiatives to drive growth. 
Any positive surprises in the upcoming earnings release could act as a catalyst for further price appreciation. 
### Sector Performance: 
 
Lifecore operates within the broader healthcare and pharmaceutical manufacturing sector, which has experienced varied performance. 
The sector is characterized by robust demand for CDMO services, driven by increasing pharmaceutical outsourcing needs. 
Lifecore's strategic focus on leveraging its integrated manufacturing capabilities positions it well to capitalize on these industry trends. 
While the sector faces regulatory and competitive challenges, Lifecore's recent achievements and market positioning suggest it is poised to outperform its peers in the near to medium term. 
In summary, Lifecore Biomedical appears to be on a promising trajectory, supported by strong financial fundamentals, undervaluation relative to intrinsic value, and favorable industry dynamics. 
Investors should consider the stock's potential for continued upside, subject to the broader market conditions and sector-specific developments. 
 
- Funds were net buyers of 

 during the previous reporting quarter. 
 
- Funds with large holdings in 

 include: 
 
- Last 10 days performance: -6% 
- Last 30 days performance: -7% 
- Last 90 days performance: -14% 
 
Some of the latest news articles: 
 - Title: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 
Publication Date: 9/23/2025 8:30:00 PM, Source: yahoo 
URL: 

 
 
 - Title: Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock? 
Publication Date: 9/12/2025 1:09:00 PM, Source: yahoo 
URL: 

 
 
 - Title: Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference 
Publication Date: 9/4/2025 8:05:00 PM, Source: yahoo 
URL: 

 
 
 - Title: Lifecore Biomedical to Participate in Upcoming Investor Conferences 
Publication Date: 9/2/2025 8:05:00 PM, Source: yahoo 
URL: 

 for more earnings alerts. Not a financial advice. Not a trading signal."